Exelixis reported $5.78B in Market Capitalization this May of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 1.78B 0.94B
AstraZeneca AZN:LN 134.46B 4.31B
Bayer BAYN:GR 46.28B 97.26M
Bluebird Bio BLUE:US $ 0.7B 0.59B
Cytokinetics CYTK:US $ 3.15B 0.68B
Eisai 4523:JP 1938.9B 551.08B
Genmab GEN:DC 162.03B 11.18B
Immunogen IMGN:US $ 1.05B 0.54B
Mirati Therapeutics MRTX:US $ 4.56B 3.54B
Nektar Therapeutics NKTR:US $ 2.49B 0.81B
Novartis NOVN:VX 195.44B 8.4B
Sanofi SNY:US 129.35B 2.11B
Xencor XNCR:US $ 1.58B 0.76B